04 March 2024 : Clinical Research
Efficacy of Bakri Intrauterine Balloon in Managing Postpartum Hemorrhage: A Comparative Analysis of Vaginal and Cesarean Deliveries with Placenta Accreta Spectrum Disorders
Feifei Chen1BCEF, Chong Zhang1BCEF, Yaping Hu1ADEG*DOI: 10.12659/MSM.943072
Med Sci Monit 2024; 30:e943072
Table 1 Characteristics analysis of women with PPH using Bakri IUBT in 198 vaginal and cesarean births.
| Vaginal birth (n=130) | Cesarean birth (n=68) | t/χ2 | P | |
|---|---|---|---|---|
| Weight (n, %) | ||||
| <70 kg | 55 (42.3) | 27 (39.7) | 0.13 | 0.724 |
| ≥70 kg | 75 (57.7) | 41 (60.3) | ||
| Maternal age (n, %) | ||||
| <35 year | 116 (89.2) | 51 (75.0) | 6.85 | 0.013 |
| ≥35 year | 14 (10.8) | 17 (25.0) | ||
| Gestational age (n, %) | ||||
| <37 w | 10 (7.7) | 9 (9.52) | 1.58 | 0.309 |
| ≥37 w | 120 (92.3) | 59 (86.8) | ||
| Parity (n, %) | ||||
| Primipara | 96 (73.8) | 45 (66.2) | 1.28 | 0.258 |
| Multipara | 34 (26.2) | 23 (33.8) | ||
| Birth number (n, %) | ||||
| Single births | 128 (98.5) | 58 (85.3) | ||
| Multiple births | 2 (1.5) | 10 (14.7) | 13.60 | 0.000 |
| Repeat cesarean section (n, %) | ||||
| No | 127 (97.7) | 64 (94.1) | 1.67 | 0.196 |
| Yes | 3 (3.3) | 4 (5.9) | ||
| Gestational diabetes (n, %) | ||||
| No | 130 (100.0) | 67 (98.5) | 1.92 | 0.166 |
| Yes | 0 (00.0) | 1 (1.5) | ||
| Gestational hypertension (n, %) | ||||
| No | 128 (98.5) | 65 (95.6) | 1.50 | 0.221 |
| Yes | 2 (1.5) | 3 (4.4) | ||
| Uterine atony (n, %) | ||||
| No | 78 (60.0) | 36 (52.9) | 0.91 | 0.340 |
| Yes | 52 (40.0) | 32 (47.1) | ||
| PAS | ||||
| No | 61 (46.9) | 32 (47.1) | 0.00 | 0.986 |
| Yes | 69 (53.1) | 36 (52.9) | ||
| Preeclampsia (n, %) | ||||
| No | 130 (100.00) | 63 (92.6) | 9.81 | 0.002 |
| Yes | 0 (0.00) | 5 (7.4) | ||
| PPH – postpartum hemorrhage; IUBT – intrauterine balloon tamponade; PAS – placenta accreta spectrum. | ||||